1 Min Read
NEW YORK, Nov 8 (Reuters) - Catalyst Pharmaceutical Partners Inc : * Catalyst Pharma drops 66.2 percent to 49 cents in premarket after cocaine de-addiction drug trial results
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.